Amanta Healthcare Ltd. IPO

Amanta Healthcare Ltd. IPO

The healthcare industry is undergoing rapid transformation, driven by innovation, patient-centric solutions, and global demand for reliable medicines. Among the trusted names in this space, Amanta Healthcare Ltd has earned a strong reputation as a leading manufacturer of sterile solutions and pharmaceutical formulations, catering to both domestic and international markets.

About the Company

Founded with the vision to provide world-class healthcare solutions, Amanta Healthcare Ltd is a prominent player in the parenteral (injectable) pharmaceutical segment. The company specializes in producing Large Volume Parenterals (LVPs), Small Volume Parenterals (SVPs), eye/ear drops, and other sterile products. With state-of-the-art facilities and advanced technology, Amanta ensures high standards of safety, efficacy, and quality in every product.

Core Strengths of Amanta Healthcare Ltd

  1. Specialized Expertise – Strong focus on sterile solutions, ensuring reliability in life-saving treatments.
  2. Global Presence – Products are exported to more than 80 countries, making Amanta a recognized Indian healthcare exporter.
  3. Quality Certifications – Compliance with international regulatory standards such as WHO-GMP, EU-GMP, and ISO certifications.
  4. Research & Innovation – Continuous investment in R&D for developing advanced drug delivery systems and cost-effective healthcare solutions.
  5. Wide Therapeutic Coverage – Products catering to critical care, nephrology, gastroenterology, anti-infectives, and supportive therapies.

Industry Position

The global injectables and parenterals market is witnessing strong growth due to rising demand for hospitalization, chronic disease management, and advanced drug delivery methods. In this landscape, Amanta Healthcare Ltd stands out as a reliable partner to hospitals, healthcare institutions, and distributors worldwide.

Growth & Future Outlook

Amanta Healthcare Ltd is expanding its footprint by:

  • Strengthening partnerships in regulated markets (Europe, Latin America, Southeast Asia, and Africa).
  • Innovating in specialized dosage forms and patient-friendly packaging.
  • Enhancing manufacturing capabilities with automation and quality-driven practices.

With its global vision, strong infrastructure, and commitment to quality, Amanta Healthcare is well-positioned to grow as a global healthcare leader in the years ahead.

Amanta Healthcare Ltd. IPO Timetable

ParticularDate
IPO Open Date01 Sep 2025
IPO Close Date03 Sep 2025
Allotment Date04 Sep 2025
IPO Listing Date09 Sep 2025

Amanta Healthcare Ltd. IPO Details

Issue TypeBookbuilding IPO
Face ValueRs. 10 Per Equity Share
IPO PriceRs. 120 to 126 Per Equity Share
Market Lot119 Share
ISIN Code
Listing AtNSE, BSE
Issue SizeApprox. Rs. 126 Crore.

Amanta Healthcare Ltd. IPO Lot Size

ApplicationLotsSharesAmount
Minimum1119Rs. 14994
Maximum131547Rs. 194922
Small HNI (Minimum)141666Rs. 209916
Big HNI (Minimum)707973Rs. 1004598

Amanta Healthcare Ltd. IPO Allotment Status

Click Here To Check IPO Allotment Status Amanta Healthcare Ltd. IPO

Click Here To Get ASBA Forms Amanta Healthcare Ltd. IPO

Company Financials :

Particular31 March 202531 March 202431 March 2023
Total Assets381.76352.12374.06
Total Revenue276.09281.61262.70
Profit After Tax10.503.63-2.11
For the year/period ended (₹ in crore)

Company Promoters:

The promoters of the Company are Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendra Kumar Patel and Milcent Appliances Private Limited.

Objects of this Issue:

  • Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat & SVP at Hariyala, Kheda, Gujarat
  • General Corporate Purposes.

Registrar & Company Details

Company Contact InformationIPO Registrar
Amanta Healthcare Ltd.

8th Floor, Shaligram Corporates
C.J. Marg
Ambli,
Ahmedabad, Gujarat, 380058
Phone: 079 67777600
Email: cs@amanta.co.in
Website: https://www.amanta.co.in/
MUFG Intime India Pvt.Ltd.





Phone: +91-22-4918 6270
Email: amantahealthcare.ipo@linkintime.co.in
Website: https://linkintime.co.in/Initial_Offer/public-issues.html

Related posts

Leave a Comment